Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608634 · ClinicalTrials.gov registry record · Phase 2
Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses
A Phase 2 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
NCT00608634 is a Phase 2 study that has completed, run by University of Arizona. The registered enrollment target is 89 participants.
The verdict
NCT00608634, a Phase 2 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy, such as perillyl alcohol, work in different ways to stop the growth of abnormal cells, either by killing the cells or by stopping them from dividing. It is not yet known which dose of topical perillyl alcohol is more effective in stopping the development of cancer in sun damaged skin. PURPOSE: This randomized phase II trial is studying high-dose topical perillyl alcohol to see how well it works compared with low-dose topical perillyl alcohol in treating patients with sun damaged skin and actinic keratoses.
Interventions
- OTHER placebo
- DRUG perillyl alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2004-05 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00608634
The ClinicalTrials.gov registry entry for NCT00608634 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00608634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00608634 about?
NCT00608634 is a clinical study titled "Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses". RATIONALE: Drugs used in chemotherapy, such as perillyl alcohol, work in different ways to stop the growth of abnormal cells, either by killing the cells or by stopping them from dividing. It is not yet known which dose of topical perillyl alcohol is more effective in stopping the development of can...
What is the current status of trial NCT00608634?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2004-05. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00608634?
The interventions under investigation include: placebo (OTHER), perillyl alcohol (DRUG).
Who is sponsoring clinical trial NCT00608634?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.